ACRO Biomedical Co., Ltd. (TPEX:6748)

ACRO Biomedical Revenue

ACRO Biomedical had revenue of 27.82M TWD in the half year ending June 30, 2026, with 32.18% growth. This brings the company's total for the last twelve months to 52.76M, up 44.54% year-over-year. In the year 2025, ACRO Biomedical had annual revenue of 38.26M, down -13.51%. That makes ACRO Biomedical the 42,772nd largest company in the world by revenue and 2,143rd in Taiwan.

• Revenue (ttm): 52.76M
• Revenue Growth: +44.54%
• P/S Ratio: 254.08
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.40B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• AGO Biomedical 38.12M 99.6%
• Other 139.00K 0.4%

By Geography

Chart

• Taiwan 24.94M 65.2%
• Vietnam 12.60M 32.9%
• Other 714.00K 1.9%

Fiscal year ended Dec 31, 2025 See the full ACRO Biomedical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.26M	-5.98M	-13.51%
Dec 31, 2024	44.23M	-6.83M	-13.38%
Dec 31, 2023	51.06M	23.43M	84.79%
Dec 31, 2022	27.63M	5.81M	26.59%
Dec 31, 2021	21.83M	3.80M	21.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error